Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1425 of 2529 entries
View as:

A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines

Phase: N/A Priority: Normal
NCT ID: NCT03580369 Org: User:
Start: 10/17/18 End: 06/14/22 Due: 06/14/23

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Phase: N/A Priority: Normal
NCT ID: NCT01396057 Org: User:
Start: 07/31/11 End: 06/30/13 Due: 06/30/14

A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT06251986 Org: User:
Start: 02/26/24 End: 12/16/24 Due: 12/16/25

An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)

Phase: N/A Priority: Normal
NCT ID: NCT03769168 Org: User:
Start: 06/07/19 End: 11/07/24 Due: 11/07/25

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04857372 Org: User:
Start: 10/21/21 End: 09/04/26 Due: 09/04/27

Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)

Phase: N/A Priority: Normal
NCT ID: NCT00879333 Org: User:
Start: 07/31/09 End: 01/31/14 Due: 01/31/15

Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC

Phase: N/A Priority: Normal
NCT ID: NCT02795429 Org: User:
Start: 06/15/16 End: 06/24/21 Due: 06/24/22

A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study

Phase: N/A Priority: Normal
NCT ID: NCT06149104 Org: User:
Start: 12/04/23 End: 08/14/24 Due: 08/14/25

Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.

Phase: N/A Priority: Normal
NCT ID: NCT05124925 Org: User:
Start: 07/27/22 End: 06/16/26 Due: 06/16/27

Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01490840 Org: User:
Start: 11/30/11 End: 07/31/14 Due: 07/31/15

Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection

Phase: N/A Priority: Normal
NCT ID: NCT05526729 Org: User:
Start: 09/02/22 End: 06/29/24 Due: 06/29/25

Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00913653 Org: User:
Start: 05/31/09 End: - Due: -

A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05067140 Org: User:
Start: 09/02/21 End: 05/25/27 Due: 05/25/28

A Proof-of-mechanism Study of Multiple, Oral Doses of Fevipiprant (QAW039) in COPD Patients With Eosinophilia

Phase: N/A Priority: Normal
NCT ID: NCT03810183 Org: User:
Start: 05/21/19 End: 01/16/20 Due: 01/16/21

Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria

Phase: N/A Priority: Normal
NCT ID: NCT03167242 Org: User:
Start: 08/02/17 End: 06/28/21 Due: 06/28/22

First-in-human, Safety, Tolerability and Pharmacokinetics Study of LRX712 in Osteoarthritic Patients

Phase: N/A Priority: Normal
NCT ID: NCT03355196 Org: User:
Start: 11/20/17 End: 03/26/19 Due: 03/26/20

Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT02292550 Org: User:
Start: 05/14/15 End: 09/26/18 Due: 09/26/19

Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00426530 Org: User:
Start: 02/28/07 End: 06/30/10 Due: 06/30/11

Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow

Phase: N/A Priority: Normal
NCT ID: NCT00172068 Org: User:
Start: 01/31/02 End: - Due: -

Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Phase: N/A Priority: Normal
NCT ID: NCT03070691 Org: User:
Start: - End: - Due: -

Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications

Phase: N/A Priority: Normal
NCT ID: NCT00097786 Org: User:
Start: 01/31/02 End: 10/31/09 Due: 10/31/10

Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02442206 Org: User:
Start: 05/18/15 End: 05/15/17 Due: 05/15/18

A Multicenter, 4-week Crossover (Total Duration 12 Weeks) to Determine the Impact of QVA149 on Nocturnal Oxygen Levels in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02233543 Org: User:
Start: 11/30/14 End: 06/26/16 Due: 06/26/17

Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders

Phase: N/A Priority: Normal
NCT ID: NCT05086744 Org: User:
Start: 12/21/21 End: 05/17/24 Due: 05/17/25

Special Drug Use-results Surveillance of Tafinlar/Mekinist

Phase: N/A Priority: Normal
NCT ID: NCT06262919 Org: User:
Start: 02/09/24 End: 12/31/31 Due: 12/31/32